4 research outputs found
Novel three-dimensional bone ‘mapping’ software can help assess progression of osseous metastases from routine CT
Imaging of bone metastasis response to therapy is a research priority. Stradwin is a new software-tool, with demonstrated sub-voxel accuracy in assessing cortical bone properties from routine CT. We applied this technology to the context of osseous metastases, with particular focus on disease progression using prostate cancer as a model. 3D–rendered ‘bone-maps’ were produced for 20 men with advanced prostate cancer, including a sub-cohort of 9 who had undergone serial scans. Correlation between baseline interpretation and assessments of progression between modalities was assessed. Bone-maps took significantly less time to interpret than CT bone windows (P < 0.001). Initial bone-mapping, without adjustment, demonstrated sensitivity and specificity for suspicious areas on CT of 70.7% and 73.1% respectively. Evaluating disease over time, concordance between bone-maps and current practice using RECIST outcomes was 100%.
This study demonstrates the feasibility and potential use of this free post-processing software in the serial assessment of osseous metastases
Comparison of bioinspired algorithms applied to cancer database
Cancer is not just a disease; it is a set of diseases. Breast cancer is the second most common cancer worldwide after lung cancer, and it represents the most frequent cause of cancer death in women (Thurtle et al. in: PLoS Med 16(3):e1002758, 2019, 1]). If it is diagnosed at an early age, the chances of survival are greater. The objective of this research is to compare the performance of method predictions: (i) Logistic Regression, (ii) K-Nearest Neighbor, (iii) K-means, (iv) Random Forest, (v) Support Vector Machine, (vi) Linear Discriminant Analysis, (vii) Gaussian Naive Bayes, and (viii) Multilayer Perceptron within a cancer database
Novel three-dimensional bone ‘mapping’ software can help assess progression of osseous metastases from routine CT
Imaging of bone metastasis response to therapy is a research priority. Stradwin is a new software-tool, with demonstrated sub-voxel accuracy in assessing cortical bone properties from routine CT. We applied this technology to the context of osseous metastases, with particular focus on disease progression using prostate cancer as a model. 3D–rendered ‘bone-maps’ were produced for 20 men with advanced prostate cancer, including a sub-cohort of 9 who had undergone serial scans. Correlation between baseline interpretation and assessments of progression between modalities was assessed. Bone-maps took significantly less time to interpret than CT bone windows (P < 0.001). Initial bone-mapping, without adjustment, demonstrated sensitivity and specificity for suspicious areas on CT of 70.7% and 73.1% respectively. Evaluating disease over time, concordance between bone-maps and current practice using RECIST outcomes was 100%. This study demonstrates the feasibility and potential use of this free post-processing software in the serial assessment of osseous metastases